Insider Trading & Ownership - Downs Christopher

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Downs Christopher
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-02-01
Purchase
2024-02-06
10:27 am
CNS Pharmaceuticals Inc.CNSPDowns Christopher
Chief Financial Officer
66,666$0.3$20,000359,916
(Direct)
View
2023-08-22
Purchase
2023-08-23
08:00 am
CNS Pharmaceuticals Inc.CNSPDowns Christopher
Chief Financial Officer
27,000$1.2658$34,17736,772
(Direct)
View
2023-04-17
Purchase
2023-04-18
08:00 am
CNS Pharmaceuticals Inc.CNSPDowns Christopher
Chief Financial Officer
3,100$3.2$9,9209,251
(Direct)
View
2021-12-06
Purchase
2021-12-07
08:30 am
CNS Pharmaceuticals Inc.CNSPDowns Christopher
Chief Financial Officer
5,000$0.9403$4,702151,500
(Direct)
View
2021-11-19
Purchase
2021-11-22
08:47 am
CNS Pharmaceuticals Inc.CNSPDowns Christopher
Chief Financial Officer
4,500$1.1537$5,192146,500
(Direct)
View
2020-08-24
Purchase
2020-08-25
7:11 pm
CNS Pharmaceuticals Inc.CNSPDowns Christopher
Chief Financial Officer
142,000$2.04$289,680142,000
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-02-01
Option Award
2024-02-06
10:27 am
2024-02-01
2029-02-01
CNS Pharmaceuticals Inc.CNSPDowns Christopher
Chief Financial Officer
133,332$0359,916
(Direct)
View
2023-04-28
Exercise
2023-05-01
6:59 pm
N/A
N/A
CNS Pharmaceuticals Inc.CNSPDowns Christopher
Chief Financial Officer
521$038,020
(Direct)
View
2023-03-29
Option Award
2023-03-31
7:28 pm
N/A
N/A
CNS Pharmaceuticals Inc.CNSPDowns Christopher
Chief Financial Officer
6,067$028,768
(Direct)
View
2023-02-09
Exercise
2023-02-10
5:34 pm
N/A
N/A
EBET Inc.EBETDowns Christopher
Director
6,300$081,300
(Direct)
View
2022-04-28
Option Award
2022-04-29
5:12 pm
N/A
N/A
CNS Pharmaceuticals Inc.CNSPDowns Christopher
Chief Financial Officer
250,000$0681,000
(Direct)
View
2022-03-11
Option Award
2022-03-14
09:40 am
N/A
N/A
CNS Pharmaceuticals Inc.CNSPDowns Christopher
Chief Financial Officer
33,000$0.31184,500
(Direct)
View
2022-02-09
Option Award
2022-02-11
4:36 pm
N/A
N/A
Esports Technologies Inc.EBETDowns Christopher
Director
6,300$081,300
(Direct)
View

Ownership
2021-04-14
9:52 pm
N/A
2031-03-05
Esports Technologies Inc.EBETDowns Christopher
Director
0$075,000
(Direct)
View
2021-02-05
Option Award
2021-02-09
5:00 pm
N/A
2031-02-05
CNS Pharmaceuticals Inc.CNSPDowns Christopher
Chief Financial Officer
131,000$0431,000
(Direct)
View
2019-11-13
Option Award
2019-11-13
5:12 pm
N/A
2029-11-13
CNS Pharmaceuticals Inc.CNSPDowns Christopher
Chief Financial Officer
300,000$0300,000
(Direct)
View